Business Insights - The cancer market outlook to 2015

Business Insights - The cancer market outlook to 2015
172 pages | Business Insights Press | Market Report | PDF | 1 MB

Global cancer prevalence rates are on the rise owing to an aging population, changing lifestyle and increasing pollution. Prevalence data is significantly influenced by the increasing diagnosis and survival rates across the global market.

Globally, lung cancer is one of the most common types of cancer, with an estimated 1.2m new cases being diagnosed every year. Among all lung cancer cases, around 42% survive after one year, yet the relative five-year survival rate for all lung cancers combined is around 15% only.

The last decade has seen a significant fall in mortality rates from breast cancer. Due to the lack of medical treatments for late-stage breast cancer, the long-term survival of patients still depends on early diagnosis, which has been improved through the contentious use of large-scale screening and public awareness programs.

Prostate cancer is one of the most commonly diagnosed cancers, and is the second leading cancerrelated cause of deaths in men, surpassed only by lung cancer. The highest incidence of this disease is seen in the US, and studies have placed black men at a higher risk of prostate cancer than men from other ethnic origins.

File is attached to premium FileSonic account please do not make any mirrors.

http://www.filesonic.com/file/...cer_market_outlook_to_2015.pdf